Name | Cinobufotalin |
---|---|
Synonyms |
14,15b-Epoxy-3b,5a,16b-trihydroxy-5b,20(22)-bufadienolide 16-acetate
(3b,5b,15b,16b)-16-(Acetyloxy)-14,15-epoxy-3,5-dihydroxybufa-20,22-dienolide MFCD00055946 Bufa-20,22-dienolide, 16- (acetyloxy)-14,15-epoxy-3,5-dihydroxy-, (3β,5β,15β,16β)- 5beta-Hydroxycinobufagin 5β-Bufa-20,22-dienolide, 14,15β-epoxy-3β,5,16β-trihydroxy-, 16-acetate (8CI) Bufa-20,22-dienolide, 16-(acetyloxy)-14,15-epoxy-3,5-dihydroxy-, (3β,5β,15β,16β)- cinobufotalin venom toad Cinobufotlin 14,15-Epoxy-14H-cyclopenta[a]phenanthrene,bufa-20,22-dienolide deriv. Cinobufotalin CINOBUFOTALIN(RG) cinobufatolin (3β,5β,15β,16β)-16-Acetoxy-3,5-dihydroxy-14,15-epoxybufa-20,22-dienolide 14,15b-Epoxy-3b,5,16b-trihydroxy-5b-bufa-20,22-dienolide 16-Acetate |
Description | Cinobufotalin is one of the bufadienolides prepared from toad venom; has anticancer activity.IC50 value:Target:in vitro: Cinobufotalin(CB) caused significant DNA fragmentation, decrease of MMP, and an increase in the intracellular Ca(2+) ion and ROS production. In addition, CB induced upregulation of Fas protein, proteolytic activation of cytochrome c, caspase-2, -3, -8 and -9 together with the activation of Bid and Bax [1]. cinobufotalin displayed considerable cytotoxicity against lung cancer cells (A549, H460 and HTB-58 lines) without inducing significant cell apoptosis. cinobufotalin mainly induces Cyp-D-dependent non-apoptotic death in cultured lung cancer cells [2]. cinobufotalin (at nmol/L) significantly inhibited HCC cell growth and survival while inducing considerable cell apoptosis. Further, cinobufotalin inhibited sphingosine kinase 1 (SphK1) activity and induced pro-apoptotic ceramide production. cinobufotalin inactivated Akt-S6K1 signaling in HepG2 cells, which was again inhibited by ceramide synthase-1 shRNA-depletion [3].in vivo: Using a mice xenograft model, we found that cinobufotalin inhibited A549 lung cancer cell growth in vivo [2]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 627.3±55.0 °C at 760 mmHg |
Melting Point | 259 - 262ºC |
Molecular Formula | C26H34O7 |
Molecular Weight | 458.544 |
Flash Point | 210.7±25.0 °C |
Exact Mass | 458.230438 |
PSA | 109.50000 |
LogP | 0.79 |
Vapour Pressure | 0.0±4.2 mmHg at 25°C |
Index of Refraction | 1.612 |
Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H300-H310-H330 |
Precautionary Statements | P260-P264-P280-P284-P302 + P350-P310 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | T+: Very toxic; |
Risk Phrases | R26/27/28 |
Safety Phrases | 22-36/37/39-45 |
RIDADR | UN 2811 |
WGK Germany | 3 |
RTECS | EI2991000 |
Packaging Group | II |
Hazard Class | 6.1(a) |
~% 1108-68-5 |
Literature: Journal of Asian Natural Products Research, , vol. 12, # 9 p. 793 - 800 |
~% 1108-68-5 |
Literature: Drug Metabolism and Disposition, , vol. 39, # 4 p. 675 - 682 |
Precursor 2 | |
---|---|
DownStream 0 |